|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 12, 2021 ) According to research report the perfusion systems market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069
Growth in the market is driven by factors such as the increasing prevalence of cardiovascular and respiratory diseases, increasing initiatives by governments and NGOs to encourage organ donation, increasing investment in cell-based research, and rising activities in biologics manufacturing.
Premium Insights
> Perfusion Systems: Market Overview
> Geographic Analysis: Perfusion Systems Market, By Type
> Cell Perfusion Systems Market, By Type
> Geographic Snapshot of the Market
By component, the cardiopulmonary Perfusion Systems Market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and other components. The oxygenators segment accounted for the largest share of the cardiopulmonary Perfusion Systems Market in 2016.
Based on technique, the ex vivo organ Perfusion Systems Market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest share of the ex vivo organ Perfusion Systems Market in 2016 and is also projected to grow at the highest CAGR during the forecast period.
The global cell Perfusion Systems Market is segmented based on the type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems.
Perfusion System Market Dynamics
Drivers
> Increasing prevalence of cardiovascular and respiratory diseases
> Rising number of organ transplantations
> Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
> Government and NGO Initiatives to Encourage Organ Donation
> Increasing Investments in Cell-Based Research
> Increase in Biologic Manufacturing
Restraints
> High Cost of Organ Transplantation
> Ethical Concerns and High Cost of Cell-Based Research
Opportunities
> Increasing Pharmaceutical Research in Emerging Markets
> Rising Preference for Continuous Manufacturing
Challenges
> Organ Supply-Demand Gap
This market is highly fragmented with different key players for the different types of perfusion systems. The major players in the cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164273069
Geographically, North America is estimated to account for the largest share of the global market, followed by Europe. The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period. This growth will be particularly centered on China, Japan, and India.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
